中/EN Contact/Message
Innovate
Sotyktu
Sotyktu
departments:皮肤科
drug:片剂
Active:Deucravacitinib
indication:银屑病
Licensor:Bristol-Myers Squibb Pharma EEIG
Approved Country/Region:EMA
Approval time:2023-03-24